57,863 research outputs found

    Análisis del estrés percibido y los niveles de cortisol en saliva en profesionales con trastorno temporomandibular.

    No full text
    López Mulet, Myrian; director de proyecto: Alvaredo Mateos, Miguel Ángel2023-2024Grado en FisioterapiaFacultad de Ciencias de la Salu

    Análisis de la traducción en la literatura fantástica

    No full text
    Bonnín Mulet, Bartomeu; director de proyecto: Alconero Gutiérrez, María Isabel2022-2023Grado en Traducción e InterpretaciónFacultad de Estudios Sociales y Lenguas Aplicada

    Desarrollo e implantación en España de las pedagogías activas en educación secundaria

    No full text
    Mulet Papió, Daniel; director de proyecto: Sánchez Rico, Ana2021-2022Máster Universitario en Profesorado de Educación Secundaria Obligatoria y Bachillerato, Formación Profesional y Enseñanza de IdiomasFacultad de Estudios Sociales y Lenguas Aplicada

    Traces and shards of self-injury: Strange accounting with “Author X”

    No full text
    In this strange account autoethnography, three or four authors explore their lived experiences with self-injury. Strange accounting is both a post-modern style of text, and a method for keeping identities concealed when risks and secrets are in play. Author X, a post-modern place-keeper for an anonymous author who may or may not have contributed to this manuscript, introduces a new dimension and layer of concealment. With Author X in-play and under erasure, the reader will never be sure if there were three or four authors on this manuscript. Through strange accounting, a post-structuralist/postmodernist frame will be applied to understanding the self-injury experience. We frame self-injury as a social practice and, for some, an everyday norm, while remaining acutely aware of the stigma surrounding the topic of self-injury. Each of us, coupled with Author X, provide the others cover to trace stories of self-injury through the literature, our flesh, and our lives

    A 2 h periodic variation in the low-mass X-ray binary Ser X-1

    No full text
    Spectroscopy of the low-mass X-ray binary Ser X-1 using the Gran Telescopio Canarias have revealed a ?2 h periodic variability that is present in the three strongest emission lines. We tentatively interpret this variability as due to orbital motion, making it the first indication of the orbital period of Ser X-1. Together with the fact that the emission lines are remarkably narrow, but still resolved, we show that a main-sequence K dwarf together with a canonical 1.4 M? neutron star gives a good description of the system. In this scenario, the most likely place for the emission lines to arise is the accretion disc, instead of a localized region in the binary (such as the irradiated surface or the stream-impact point), and their narrowness is due instead to the low inclination (?10°) of Ser X-1

    Diseño de la instalación eléctrica en baja tensión de una estación de bombas de riego

    No full text
    El objeto del presente proyecto tiene por finalidad el diseño, cálculo y valoración de la instalación eléctrica en Baja Tensión del cabezal de riego comunitario, dentro del plan de Reconversión de Riego Tradicional a Riego Localizado en el Sector X de la Margen Derecha del Canal Júcar-Turia en el término municipal de Picassent, zona de ¿El Plá¿.Alberola Mulet, J. (2007). Diseño de la instalación eléctrica en baja tensión de una estación de bombas de riego. Universitat Politècnica de València. https://riunet.upv.es/handle/10251/19200Archivo delegad

    Relations between x-ray timing features and spectral parameters of galactic black hole x-ray binaries

    No full text
    We present a study of correlations between spectral and timing parameters for a sample of black hole X-ray binary candidates. Data are taken from GX 339-4, H 1743-322, and XTE J1650-500, as the Rossi X-ray Timing Explorer (RXTE) observed complete outbursts of these sources. In our study we investigate outbursts that happened before the end of 2009 to make use of the high-energy coverage of the HEXTE detector and select observations that show a certain type of quasi-periodic oscillations (type-C QPOs). The spectral parameters are derived using the empirical convolution model simpl to model the Comptonized component of the emission together with a disc blackbody for the emission of the accretion disc. Additional spectral features, namely a reflection component, a high-energy cut-off, and excess emission at 6.4 keV, are taken into account. Our investigations confirm the known positive correlation between photon index and centroid frequency of the QPOs and reveal an anti-correlation between the fraction of up-scattered photons and the QPO frequency. We show that both correlations behave as expected in the “sombrero” geometry. Furthermore, we find that during outburst decay the correlation between photon index and QPO frequency follow a general track, independent of individual outbursts

    Is early antithrombotic therapy necessary after tissue mitral valve replacement?

    No full text
    BACKGROUND AND AIM OF THE STUDY:Patients with prosthetic heart valves have a higher risk of developing valve thrombosis and arterial thromboembolism. Antithrombotic therapy during the early postoperative period after biologic mitral valve replacement (MVR) is controversial. Hence, a retrospective study was conducted to investigate the efficacy of different antithrombotic therapies in patients after MVR with bioprostheses.METHODS:Between January 2000 and January 2006, a total of 99 patients presenting with preoperative sinus rhythm underwent isolated bioprosthetic MVR. Of these patients, 59 (58%) received a bovine pericardial xenograft, and 40 (42%) a porcine bioprosthesis. The postoperative antithrombotic therapy was prescribed according to the surgeon's preference.RESULTS:Fifty-one (51%) patients received acetylsalicylic acid (ASA group, 100 mg/day), 12 (13%) did not receive any specific antithrombotic therapy (NT group), and 36 (36%) received a vitamin K antagonist (VKA group, INR 2-3). The primary endpoints were the rate of cerebral ischemic events, bleeding events, and survival. The mean follow up was 23 months (range: 3-68 months). There were five early deaths (5%), and eight late deaths (8%). There were five episodes of cerebral ischemic events; these included three patients (8.3%) in the VKA group, one patient (2.0%) in ASA group, and one patient (8.3%) in the NT group (p = 0.351). Of these episodes, two occurred between 24 h and three months after surgery. Only one (2.8%) episode of major bleeding occurred (in the VKA group), due to poor anticoagulation management.CONCLUSION:Each of the antithrombotic therapies evaluated appeared to be safe. There was no evidence to suggest that any specific antithrombotic therapy would be superior in preventing valve thrombosis in patients undergoing bioprosthetic MVR

    Is early antithrombotic therapy necessary after tissue mitral valve replacement?

    No full text
    Patients with prosthetic heart valves have a higher risk of developing valve thrombosis and arterial thromboembolism. Antithrombotic therapy during the early postoperative period after biologic mitral valve replacement (MVR) is controversial. Hence, a retrospective study was conducted to investigate the efficacy of different antithrombotic therapies in patients after MVR with bioprostheses. METHODS: Between January 2000 and January 2006, a total of 99 patients presenting with preoperative sinus rhythm underwent isolated bioprosthetic MVR. Of these patients, 59 (58%) received a bovine pericardial xenograft, and 40 (42%) a porcine bioprosthesis. The postoperative antithrombotic therapy was prescribed according to the surgeon's preference. RESULTS: Fifty-one (51%) patients received acetylsalicylic acid (ASA group, 100 mg/day), 12 (13%) did not receive any specific antithrombotic therapy (NT group), and 36 (36%) received a vitamin K antagonist (VKA group, INR 2-3). The primary endpoints were the rate of cerebral ischemic events, bleeding events, and survival. The mean follow up was 23 months (range: 3-68 months). There were five early deaths (5%), and eight late deaths (8%). There were five episodes of cerebral ischemic events; these included three patients (8.3%) in the VKA group, one patient (2.0%) in ASA group, and one patient (8.3%) in the NT group (p = 0.351). Of these episodes, two occurred between 24 h and three months after surgery. Only one (2.8%) episode of major bleeding occurred (in the VKA group), due to poor anticoagulation management. CONCLUSION: Each of the antithrombotic therapies evaluated appeared to be safe. There was no evidence to suggest that any specific antithrombotic therapy would be superior in preventing valve thrombosis in patients undergoing bioprosthetic MVR
    corecore